Perspective: Testing failures

Nature. 2012 May 17;485(7398):S17. doi: 10.1038/485s17a.
No abstract available

MeSH terms

  • Clinical Trials, Phase III as Topic* / methods
  • Diabetes Mellitus / drug therapy*
  • Dose-Response Relationship, Drug
  • Humans
  • Interleukin-1 / antagonists & inhibitors
  • Patient Selection
  • Treatment Failure

Substances

  • Interleukin-1